Neurofilament light chain as a potential biomarker in patients with hereditary ATTR-polyneuropathy in NEURO-TTRansform

被引:0
|
作者
Conceicao, I. [1 ]
Polydefkis, M. [2 ]
Obici, L. [3 ]
Adams, D. [4 ]
Gillmore, J. [5 ]
Masri, A. [6 ]
Brannagan, T., II [7 ]
Coelho, T. [8 ]
Jung, S. [9 ]
Wessman, P. [10 ]
Mathews, J. [9 ]
Viney, N. [9 ]
Chen, J. [11 ]
Cruz, M. Waddington [12 ]
机构
[1] Univ Lisbon, Hosp Santa Maria, Ctr Hosp Univ Lisboa Norte, Lisbon, Portugal
[2] Johns Hopkins Univ, Baltimore, MD USA
[3] IRCCS Fdn Policlin San Matteo, Amyloidosis Res & Treatment Ctr, Pavia, Italy
[4] Hop Bicetre, Le Kremlin Bicetre, France
[5] UCL, Ctr Amyloidosis, London, England
[6] Oregon Hlth & Sci Univ, Portland, OR USA
[7] Columbia Univ, Neurol Inst, Irving Med Ctr, New York, NY USA
[8] Hosp Santo Antonio, Ctr Hosp Univ Porto, Porto, Portugal
[9] Ionis Pharmaceut Inc, Carlsbad, CA USA
[10] AstraZeneca, Gothenburg, Sweden
[11] AstraZeneca, Wilmington, DE USA
[12] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EPR-225
引用
收藏
页码:271 / 272
页数:2
相关论文
共 50 条
  • [21] Serum neurofilament light chain as an early diagnostic biomarker for critical illness polyneuropathy
    Zulehner, Gudrun
    Schoergenhofer, Christian
    Rommer, Paulus
    Merrelaar, Marieke
    Behrens, Sybille
    Ponleitner, Markus
    Herkner, Harald
    Staudinger, Thomas
    Zauner, Christian
    Roth, Dominik
    Altmann, Patrick
    Kienbacher, Calvin Lukas
    MINERVA ANESTESIOLOGICA, 2023, 89 (12) : 1099 - 1104
  • [22] Rationale and Design of NEURO-TTRansform, a Phase 3 Study to Evaluate the Efficacy and Safety of AKCEA-TTR-LRx (ION-682884) in Patients with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
    Khella, Sami
    Gertz, Morie A.
    Coelho, Teresa
    Monteiro, Cecilia
    Tai, Li-Jung
    Viney, Nicholas
    Buchele, Gustavo
    Brambatti, Michela
    Tsimikas, Sotirios
    Jung, Shiangtung
    O'Dea, Louis St. L.
    Schneider, Eugene
    Geary, Richard
    Monia, Brett
    NEUROLOGY, 2020, 94 (15)
  • [23] Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis
    Ticau, Simina
    Sridharan, Gautham, V
    Tsour, Shira
    Cantley, William L.
    Chan, Amy
    Gilbert, Jason A.
    Erbe, David
    Aldinc, Emre
    Reilly, Mary M.
    Adams, David
    Polydefkis, Michael
    Fitzgerald, Kevin
    Vaishnaw, Akshay
    Nioi, Paul
    NEUROLOGY, 2021, 96 (03) : E412 - E422
  • [24] Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegia
    Kessler, Christoph
    Serna-Higuita, Lina M.
    Rattay, Tim W.
    Maetzler, Walter
    Wurster, Isabel
    Hayer, Stefanie
    Wilke, Carlo
    Hengel, Holger
    Reichbauer, Jennifer
    Armbruster, Marcel
    Schoels, Ludger
    Martus, Peter
    Schuele, Rebecca
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (05): : 1122 - 1131
  • [25] NEUROFILAMENT LIGHT CHAIN AS POTENTIAL BIOMARKER FOR OVERT HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS
    Van Doorn, Diederick
    De Wit, Koos
    Mol, Bregje
    Van Vught, Lonneke
    Nevens, Frederik
    Beuers, Ulrich H.
    Ponsioen, Cyriel Y.
    Teunissen, Charlotte
    Takkenberg, Bart
    HEPATOLOGY, 2023, 78 : S1402 - S1402
  • [26] Rationale and Design of NEURO-TTRansform, a phase 3 study evaluating the efficacy and safety of AKCEA-TTR-LRx in patients with hereditary transthyretin-mediated Amyloid Polyneuropathy (hATTR-PN)
    Tai, L.
    Obici, L.
    Giilmore, J.
    Viney, N.
    Monteiro, C.
    Buchele, G.
    Brambatti, M.
    Tskimikas, S.
    Jung, S.
    O'dea, L.
    Schneider, E.
    Geary, R.
    Monia, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 514 - 514
  • [27] Neurofilament light chain: a novel biomarker in patients with glaucoma
    Comacchio, Francesco
    Mariotto, Sara
    Neri, Enrico
    Bonora, Adriana
    Morbio, Roberta
    Pichler, Andreas
    Marchini, Giorgio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [28] Neurofilament light chain as a potential biomarker in spinal muscular atrophy
    de Pommerol, H. Jullien
    Kieloch, A.
    Leppert, D.
    Peters, T.
    Theil, D.
    Valentin, M.
    Voltz, E.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S111 - S111
  • [29] Rationale and Design of Neuro-Ttransform, a Phase 3 Study to Evaluate the Efficacy and Safety of AKCEA-TTR-LRx (ion-682884) in Patients with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy (hATTR-PN)
    Khella, Sami
    Gertz, Morie A.
    Berk, John L.
    Tai, Li-Jung
    Viney, Nicholas J.
    Monteiro, Cecilia
    Buchele, Gustavo
    Brambatti, Michela
    Tsimikas, Sotirios
    Jung, Shiangtung W.
    O'Dea, Louis St. L.
    Schneider, Eugene
    Geary, Richard S.
    Monia, Brett P.
    ANNALS OF NEUROLOGY, 2020, 88 : S228 - S229
  • [30] Neurofilament light chain as a potential biomarker of disease status in Friedreich ataxia
    Clay, Alexandra
    Obrochta, Kristin M.
    Soon, Russell K., Jr.
    Russell, Christopher B.
    Lynch, David R.
    JOURNAL OF NEUROLOGY, 2020, 267 (09) : 2594 - 2598